Parallax Volatility Advisers
GSK icon

Parallax Volatility Advisers’s GSK GSK Stock Holding History

Parallax Volatility Advisers’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-53,800
Closed -$1.82M – 1784
2024
Q4 		$1.82M Buy
53,800
+23,900
+80% +$860K ﹤0.01% 1151
2024
Q3 		$1.22M Buy
+29,900
New +$1.22M ﹤0.01% 1301
2023
Q1 		– Sell
-17,500
Closed -$615K – 2904
2022
Q4 		$615K Hold
17,500
– – ﹤0.01% 1817
2022
Q3 		$515K Sell
17,500
-76,260
-81% -$2.89M ﹤0.01% 1970
2022
Q2 		$5.1M Buy
93,760
+86,160
+1,134% +$4.76M ﹤0.01% 970
2022
Q1 		$414K Sell
7,600
-24,800
-77% -$1.35M ﹤0.01% 1965
2021
Q4 		$1.79M Sell
32,400
-240
-0.7% -$12.5K ﹤0.01% 1689
2021
Q3 		$1.56M Buy
32,640
+32,560
+40,700% +$1.64M ﹤0.01% 1774
2021
Q2 		$4K Sell
80
-2,720
-97% -$131K ﹤0.01% 2830
2021
Q1 		$126K Sell
2,800
-8,960
-76% -$407K ﹤0.01% 2793
2020
Q4 		$541K Sell
11,760
-9,120
-44% -$419K ﹤0.01% 2461
2020
Q3 		$985K Buy
20,880
+11,360
+119% +$569K ﹤0.01% 1990
2020
Q2 		$484K Buy
+9,520
New +$488K ﹤0.01% 1989
2019
Q1 		– Sell
-4,560
Closed -$218K – 3246
2018
Q4 		$218K Buy
+4,560
New +$225K ﹤0.01% 1721
2015
Q3 		– Sell
-68,160
Closed -$3.55M – 3352
2015
Q2 		$3.55M Buy
68,160
+68,000
+42,500% +$3.83M 0.01% 846
2015
Q1 		$9K Buy
+160
New +$9.17K ﹤0.01% 3956

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Parallax Volatility Advisers's GSK Position: Q1 2025 in Review

Parallax Volatility Advisers sold out of GSK (GSK) in Q1 2025, closing a stake of 8,766 shares — an estimated $296K sold.

Parallax Volatility Advisers first reported a position in GSK in Q3 2013 and held it in 19 quarters. The position peaked at $1.53B in Q2 2022. 859 funds tracked by Wall St. Rank hold GSK as of Q1 2025.

  • Parallax Volatility Advisers reported no remaining GSK position as of Q1 2025 after selling out during the quarter.
  • Parallax Volatility Advisers sold 8,766 GSK shares in Q1 2025, an estimated $296K.
  • Parallax Volatility Advisers first reported a position in GSK in Q3 2013 and held it in 19 quarters.
  • Parallax Volatility Advisers's GSK position peaked at $1.53B in Q2 2022.
  • 859 funds tracked by Wall St. Rank held GSK as of Q1 2025.

Based on Parallax Volatility Advisers's 13F filing for Q1 2025, filed 15 May 2025.